These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 20889205

  • 1. Targeting of polymeric nanoparticles to lung metastases by surface-attachment of YIGSR peptide from laminin.
    Sarfati G, Dvir T, Elkabets M, Apte RN, Cohen S.
    Biomaterials; 2011 Jan; 32(1):152-61. PubMed ID: 20889205
    [Abstract] [Full Text] [Related]

  • 2. Polymeric nanospheres modified with YIGSR peptide for tumor targeting.
    Dubey PK, Singodia D, Vyas SP.
    Drug Deliv; 2010 Jan; 17(7):541-51. PubMed ID: 20560774
    [Abstract] [Full Text] [Related]

  • 3. Liposomes modified with YIGSR peptide for tumor targeting.
    Dubey PK, Singodia D, Vyas SP.
    J Drug Target; 2010 Jun; 18(5):373-80. PubMed ID: 20020817
    [Abstract] [Full Text] [Related]

  • 4. Laminin receptor-targeted etoposide loaded polymeric micelles: a novel approach for the effective treatment of tumor metastasis.
    Ukawala M, Chaudhari K, Rajyaguru T, Manjappa AS, Murthy RS, Gude R.
    J Drug Target; 2012 Jan; 20(1):55-66. PubMed ID: 21967151
    [Abstract] [Full Text] [Related]

  • 5. Bioconjugation of laminin-related peptide YIGSR with polyvinyl pyrrolidone increases its antimetastatic effect due to a longer plasma half-life.
    Mu Y, Kamada H, Kodaira H, Sato K, Tsutsumi Y, Maeda M, Kawasaki K, Nomizu M, Yamada Y, Mayumi T.
    Biochem Biophys Res Commun; 1999 Nov 02; 264(3):763-7. PubMed ID: 10544005
    [Abstract] [Full Text] [Related]

  • 6. Synthetic cell-adhesive laminin peptide YIGSR conjugated with polyethylene glycol has improved antimetastatic activity due to a longer half-life in blood.
    Kaneda Y, Yamamoto S, Kihira T, Tsutsumi Y, Nakagawa S, Miyake M, Kawasaki K, Mayumi T.
    Invasion Metastasis; 1995 Nov 02; 15(3-4):156-62. PubMed ID: 8621271
    [Abstract] [Full Text] [Related]

  • 7. Effect of Matrigel and laminin peptide YIGSR on tumor growth and metastasis.
    Yamamura K, Kibbey MC, Jun SH, Kleinman HK.
    Semin Cancer Biol; 1993 Aug 02; 4(4):259-65. PubMed ID: 8400148
    [Abstract] [Full Text] [Related]

  • 8. Pentapeptide YIGSR-mediated HT-1080 fibrosarcoma cells targeting of adriamycin encapsulated in sterically stabilized liposomes.
    Lopez-Barcons LA, Polo D, Reig F, Fabra A.
    J Biomed Mater Res A; 2004 Apr 01; 69(1):155-63. PubMed ID: 14999763
    [Abstract] [Full Text] [Related]

  • 9. Preparation and evaluation of N-caproyl chitosan nanoparticles surface modified with glycyrrhizin for hepatocyte targeting.
    Lin A, Chen J, Liu Y, Deng S, Wu Z, Huang Y, Ping Q.
    Drug Dev Ind Pharm; 2009 Nov 01; 35(11):1348-55. PubMed ID: 19832635
    [Abstract] [Full Text] [Related]

  • 10. In vivo binding of the radioiodinated peptide YIGSR on B16 melanoma cells.
    Kouzi-Koliakos K, Koliakos G, Trontzos C, Papageorgiou A, Iliadis S, Triantos A, Dimitriadou A, Kanellaki M.
    Invasion Metastasis; 1996 Nov 01; 16(6):322-9. PubMed ID: 9371232
    [Abstract] [Full Text] [Related]

  • 11. Cell-specific targeting in the mouse inner ear using nanoparticles conjugated with a neurotrophin-derived peptide ligand: potential tool for drug delivery.
    Roy S, Johnston AH, Newman TA, Glueckert R, Dudas J, Bitsche M, Corbacella E, Rieger G, Martini A, Schrott-Fischer A.
    Int J Pharm; 2010 May 10; 390(2):214-24. PubMed ID: 20153412
    [Abstract] [Full Text] [Related]

  • 12. Melanoma cells selected for adhesion to laminin peptides have different malignant properties.
    Yamamura K, Kibbey MC, Kleinman HK.
    Cancer Res; 1993 Jan 15; 53(2):423-8. PubMed ID: 8417834
    [Abstract] [Full Text] [Related]

  • 13. Antiidiotypic antibodies carrying the "internal image" of peptide YIGSR inhibit spontaneous metastasis of Lewis lung carcinoma in mice.
    Koliakos KK, Sapountzi Z, Papageorgiou A, Trachana V, Kotsinou S, Koliakos G.
    In Vivo; 2002 Jan 15; 16(6):511-8. PubMed ID: 12494895
    [Abstract] [Full Text] [Related]

  • 14. Modification of the C16Y peptide on nanoparticles is an effective approach to target endothelial and cancer cells via the integrin receptor.
    Hamano N, Negishi Y, Fujisawa A, Manandhar M, Sato H, Katagiri F, Nomizu M, Aramaki Y.
    Int J Pharm; 2012 May 30; 428(1-2):114-7. PubMed ID: 22421321
    [Abstract] [Full Text] [Related]

  • 15. Multimeric forms of Tyr-Ile-Gly-Ser-Arg (YIGSR) peptide enhance the inhibition of tumor growth and metastasis.
    Nomizu M, Yamamura K, Kleinman HK, Yamada Y.
    Cancer Res; 1993 Aug 01; 53(15):3459-61. PubMed ID: 8339246
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Identification of an active site on the laminin alpha5 chain globular domain that binds to CD44 and inhibits malignancy.
    Hibino S, Shibuya M, Engbring JA, Mochizuki M, Nomizu M, Kleinman HK.
    Cancer Res; 2004 Jul 15; 64(14):4810-6. PubMed ID: 15256450
    [Abstract] [Full Text] [Related]

  • 20. Inhibition by human recombinant tissue inhibitor of metalloproteinases of human amnion invasion and lung colonization by murine B16-F10 melanoma cells.
    Schultz RM, Silberman S, Persky B, Bajkowski AS, Carmichael DF.
    Cancer Res; 1988 Oct 01; 48(19):5539-45. PubMed ID: 3416307
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.